Breakthrough humanized mouse model offers new insights for immunotherapy development

FHS
July 5, 2024
11:03 pm

A breakthrough for biomedical research promises new insight into immunotherapy development and disease modeling.

Semaglutide lowers COVID-19-related deaths in cardiovascular patients with obesity

Semaglutide, the popular anti-obesity drug, reduced the rates of COVID-19-related adverse events, including death, in those who had overweight or obesity and established cardiovascular disease

August 30, 2024

Bolt Biotherapeutics revamps as it drops lead cancer asset, changes CEO and trims headcount

Bolt Biotherapeutics is reshuffling to cut costs and extend its cash runway to the second half of 2026. The California biotech said Tuesday afternoon that

May 16, 2024

Joe Panetta to step down as Biocom California CEO

Joe Panetta, who has led the trade group Biocom California for 25 years, is slated to step down as president and CEO at the end

May 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.